Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
      • Breast Cancer
      • GU Oncology
    • New Approvals
      • Hematology
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
    • Tox Check
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
      • Hematology
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
      • Head and Neck Cancers
  • Clinical Insights
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastroesophageal Cancer
      • Gastric/GEJ Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Conferences
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
      • Breast Cancer
      • GU Oncology
    • New Approvals
      • Hematology
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
    • Tox Check
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
      • Hematology
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
      • Head and Neck Cancers
  • Clinical Insights
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastroesophageal Cancer
      • Gastric/GEJ Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • Hematology
    • Lung Cancer
  • Events

Explore Videos, Articles & More

MIBC

Home / Clinical Insights / GU Oncology / Bladder Cancer / MIBC
EP. 6: Practice-Changing Insights From the NIAGARA Trial
EP. 6: Practice-Changing Insights From the NIAGARA Trial

Petros Grivas, MD, PhD

Ep. 5: NIAGARA Trial: Perioperative Durvalumab Enhances DFS in MIBC
Ep. 5: NIAGARA Trial: Perioperative Durvalumab Enhances DFS in MIBC

Joshua Meeks, MD, PhD

Ep. 4: The Oncologist’s Role in Counseling Patients With MIBC Through Complex Treatment Decisions
Ep. 4: The Oncologist’s Role in Counseling Patients With MIBC Through Complex Treatment Decisions

Karine Tawagi, MD

Ep. 3: Key Takeaways From the NIAGARA Trial for Patients With MIBC
Ep. 3: Key Takeaways From the NIAGARA Trial for Patients With MIBC

Neal Shore, MD, FACS

Ep. 2: Clinical Implications of Circulating Tumor DNA in MIBC
Ep. 2: Clinical Implications of Circulating Tumor DNA in MIBC

Petros Grivas, MD, PhD, Joshua Meeks, MD, PhD

Ep. 1: Current Treatment Strategies for Muscle-Invasive Bladder Cancer
Ep. 1: Current Treatment Strategies for Muscle-Invasive Bladder Cancer

Karine Tawagi, MD

NIAGARA Trial: Perioperative Durvalumab for MIBC (Full Video)
NIAGARA Trial: Perioperative Durvalumab for MIBC (Full Video)

Joshua Meeks, MD, PhD, Karine Tawagi, MD, Neal Shore, MD, FACS, Petros Grivas, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Upcoming Events
  • Follow on X
  • Follow on LinkedIn
  • Follow on YouTube

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Authors
  • Contact Us

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2026 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology